Aurora Cannabis Inc. (NASDAQ:ACB – Free Report) – Stock analysts at Roth Capital boosted their Q3 2025 earnings per share (EPS) estimates for shares of Aurora Cannabis in a report released on Wednesday, August 7th. Roth Capital analyst W. Kirk now expects that the company will post earnings per share of $0.00 for the quarter, up from their prior forecast of ($0.09). The consensus estimate for Aurora Cannabis’ current full-year earnings is ($0.50) per share. Roth Capital also issued estimates for Aurora Cannabis’ Q4 2025 earnings at $0.04 EPS.
Aurora Cannabis (NASDAQ:ACB – Get Free Report) last released its earnings results on Thursday, June 20th. The company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.29. Aurora Cannabis had a negative net margin of 26.97% and a negative return on equity of 9.34%. The company had revenue of $49.98 million during the quarter, compared to analysts’ expectations of $51.28 million.
Aurora Cannabis Price Performance
Institutional Trading of Aurora Cannabis
Several large investors have recently added to or reduced their stakes in the company. Virtu Financial LLC purchased a new stake in shares of Aurora Cannabis in the 1st quarter valued at $727,000. Vanguard Personalized Indexing Management LLC purchased a new stake in Aurora Cannabis in the fourth quarter valued at $42,000. Concurrent Investment Advisors LLC purchased a new stake in Aurora Cannabis in the first quarter valued at $90,000. Headlands Technologies LLC acquired a new stake in Aurora Cannabis during the 1st quarter worth about $166,000. Finally, TD Asset Management Inc purchased a new position in shares of Aurora Cannabis during the 2nd quarter valued at about $255,000. Hedge funds and other institutional investors own 47.63% of the company’s stock.
About Aurora Cannabis
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Recommended Stories
- Five stocks we like better than Aurora Cannabis
- How to Effectively Use the MarketBeat Ratings Screener
- How to Invest in Silver: A Beginner’s Guide
- Following Congress Stock Trades
- Monday.com’s Stock Results Will Brighten Any Investor’s Week
- Bank Stocks – Best Bank Stocks to Invest In
- 3 Must-Watch Stocks After a Bullish Goldman Sachs Recommendation
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.